News | Cardiac Imaging | April 23, 2024

CDL Nuclear Technologies Launches New Mobile Cardiac PET/CT Trailer

CDL now offers three solutions for cardiovascular imaging needs

CDL now offers three solutions for cardiovascular imaging needs

April 23, 2024 — CDL Nuclear Technologies, a pioneer in advanced diagnostic solutions, is proud to announce the launch of its latest innovation: the Mobile dedicated Cardiac PET/CT Trailer. This cutting-edge mobile solution is designed to revolutionize cardiac care by directly providing state-of-the-art cardiac PET/CT imaging services to medical facilities on their schedule.

Positioned as a low-risk, high-value option, the Mobile Cardiac PET/CT Trailer is aimed at enhancing cardiac programs across various medical facilities and practices. It offers an unparalleled opportunity for institutions to upgrade their cardiac care services without the hefty initial investment typically required for advanced diagnostic tools.

The Mobile Cardiac PET/CT Trailer is designed for and is especially beneficial for facilities that do not have on-site advanced cardiovascular imaging capabilities, have limited access to innovative imaging tools or are looking to expand their cardiovascular service line offerings. Designed for seamless integration, the trailer allows hospitals and medical facilities to expand their cardiac care imaging with minimal financial and operational risk. CDL provides this service in compliance with all healthcare regulations.

Lon Wilson, the chief executive officer at CDL Nuclear Technologies, emphasizes, "Recognizing the distinct nature and specific requirements of each medical facility in terms of their Cardiac PET/CT capabilities, we provide a spectrum of solutions tailored to enhance cardiac care programs. Our latest innovation, the dedicated Mobile Cardiac PET/CT Trailer, introduces a flexible and resourceful option, empowering hospitals to advance their provision of cardiac care services on their own terms."

The Mobile Cardiac PET/CT Trailer marks CDL Nuclear Technologies' third flexible solution, which ranges from complete end-to-end PET/CT build-outs to mobile, on-demand daily use Rubidium-82 radioisotope services. Wilson adds, "CDL is going back to its roots when we operated a mobile fleet of diagnostic modalities dating back to 1992. In 2003, CDL Nuclear was born, and we are making offering Cardiac PET easier than ever before; an expansion of our existing services now includes bringing cardiac PET to your doorstep and making it possible to offer patients this advanced, accurate and highly requested diagnostic modality. The acceptance of cardiac PET as the gold standard in the non-invasive assessment of coronary disease aligns with the stated goals of Medicare in reducing costs, reducing unnecessary hospitalizations and improving patient outcomes and we are extremely proud to be a part of aiding hospitals and physicians alike to meet these tremendous achievements”.

For more information: cdl-mobile-trailers-7.webflow.io


Related Content

News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Home July 25, 2024
Home
News | PET-CT

July 11, 2022 – The American Society of Nuclear Cardiology (ASNC) and the Society of Nuclear Medicine and Molecular ...

Home July 11, 2022
Home
News | PET-CT

July 13, 2021 — In a recent blog, the American Society of Nuclear Cardiology (ASNC) reported that Humana, one of the ...

Home July 13, 2021
Home
Feature | PET-CT | Dave Fornell, Editor

As hospital imaging departments look to replace aging nuclear scanners with updated technology, many are asking if ...

Home February 19, 2020
Home
Videos | PET-CT

Rupa Sanghani, M.D., FASNC, associate professor, Rush Medical College, director of nuclear cardiology and stress ...

Home October 30, 2019
Home
News | PET-CT

March 5, 2019 — Siemens Healthineers’ new Biograph Vision positron emission tomography/computed tomography (PET/CT) ...

Home March 06, 2019
Home
Technology | PET-CT

September 26, 2018 — Bruker recently announced the introduction of the new preclinical PET/CT Si78 scanner for whole ...

Home September 26, 2018
Home
Technology | PET-CT

June 21, 2018 — Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system ...

Home June 21, 2018
Home
Technology | PET-CT

June 5, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Biograph Vision, a new positron emission ...

Home June 05, 2018
Home
News | PET-CT

July 25, 2017 — Using a new nuclear imaging technique that can diagnose cardiac sarcoidosis much more accurately than ...

Home July 25, 2017
Home
Subscribe Now